Citadel Advisors’s Quorum Health Corporation QHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-13,249
Closed -$6K 10940
2020
Q1
$6K Buy
+13,249
New +$12.5K ﹤0.01% 9489
2018
Q4
Sell
-12,473
Closed -$52.4K 10111
2018
Q3
$73K Buy
+12,473
New +$57.3K ﹤0.01% 8695
2018
Q2
Sell
-45,893
Closed -$376K 9515
2018
Q1
$376K Buy
45,893
+13,960
+44% +$91.5K ﹤0.01% 6376
2017
Q4
$199K Buy
31,933
+19,183
+150% +$96.3K ﹤0.01% 7124
2017
Q3
$66K Sell
12,750
-10,075
-44% -$41K ﹤0.01% 7134
2017
Q2
$95K Sell
22,825
-26,260
-53% -$108K ﹤0.01% 6928
2017
Q1
$267K Sell
49,085
-37,101
-43% -$302K ﹤0.01% 6057
2016
Q4
$627K Buy
+86,186
New +$519K ﹤0.01% 4552

Other funds holding QHC

Citadel Advisors's QHC Position: Q2 2020 in Review

Citadel Advisors sold out of Quorum Health Corporation (QHC) in Q2 2020, closing a stake of 13,249 shares — an estimated $6K sold.

Citadel Advisors first reported a position in QHC in Q4 2016 and held it in 8 quarters. The position peaked at $627K in Q4 2016. 9 funds tracked by Wall St. Rank hold QHC as of Q2 2020.

  • Citadel Advisors reported no remaining Quorum Health Corporation position as of Q2 2020 after selling out during the quarter.
  • Citadel Advisors sold 13,249 Quorum Health Corporation shares in Q2 2020, an estimated $6K.
  • Citadel Advisors first reported a position in Quorum Health Corporation in Q4 2016 and held it in 8 quarters.
  • Citadel Advisors's Quorum Health Corporation position peaked at $627K in Q4 2016.
  • 9 funds tracked by Wall St. Rank held Quorum Health Corporation as of Q2 2020.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.